$BBAI
BigBear.ai Holdings Inc

2021 Q1 Form 10-Q Financial Statement

#000156459021028389 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1
Revenue $35.57M
YoY Change
Cost Of Revenue $25.29M
YoY Change
Gross Profit $10.28M
YoY Change
Gross Profit Margin 28.9%
Selling, General & Admin $10.11M
YoY Change
% of Gross Profit 98.39%
Research & Development $928.0K
YoY Change
% of Gross Profit 9.03%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.04M
YoY Change
Operating Profit -$762.0K
YoY Change
Interest Expense $1.860M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$22.12K
YoY Change
Pretax Income -$2.621M
YoY Change
Income Tax -$184.0K
% Of Pretax Income
Net Earnings -$2.437M
YoY Change
Net Earnings / Revenue -6.85%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02
COMMON SHARES
Basic Shares Outstanding 105.0M shares
Diluted Shares Outstanding 105.0M shares

Balance Sheet

Concept 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.173M
YoY Change
Cash & Equivalents $9.928M
Short-Term Investments
Other Short-Term Assets $812.8K
YoY Change
Inventory
Prepaid Expenses $812.8K
Receivables
Other Receivables
Total Short-Term Assets $2.986M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $358.8M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $358.8M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.986M
Total Long-Term Assets $358.8M
Total Assets $361.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.63K
YoY Change
Accrued Expenses $362.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $20.48K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $435.3K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $12.77M
YoY Change
Total Long-Term Liabilities $12.77M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $435.3K
Total Long-Term Liabilities $12.77M
Total Liabilities $13.20M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$647.9K
YoY Change
Common Stock $5.648M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.99M
YoY Change
Total Liabilities & Shareholders Equity $361.8M
YoY Change

Cashflow Statement

Concept 2021 Q1
OPERATING ACTIVITIES
Net Income -$2.437M
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $893.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $170.0K
YoY Change
Acquisitions $224.0K
YoY Change
Other Investing Activities -$358.8M
YoY Change
Cash From Investing Activities -$394.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$351.6M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$275.0K
YoY Change
NET CHANGE
Cash From Operating Activities $893.0K
Cash From Investing Activities -$394.0K
Cash From Financing Activities -$275.0K
Net Change In Cash $224.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $893.0K
Capital Expenditures $170.0K
Free Cash Flow $723.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 gigu Holding Period Of Shares For Completion Of Initial Business Combination
HoldingPeriodOfSharesForCompletionOfInitialBusinessCombination
P12M
CY2021Q1 gigu Number Of Trading Period For Transfer Of Shares
NumberOfTradingPeriodForTransferOfShares
P20D
CY2021Q1 gigu Number Of Consecutive Trading Period For Transfer Of Shares
NumberOfConsecutiveTradingPeriodForTransferOfShares
P30D
CY2021Q1 gigu Period After Completion Of Business Combination To Allow Transfer Of Shares
PeriodAfterCompletionOfBusinessCombinationToAllowTransferOfShares
P30D
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 gigu Fair Value Assumption Expected Term
FairValueAssumptionExpectedTerm
P6Y
CY2021Q1 gigu Fair Value Assumption Expected Term
FairValueAssumptionExpectedTerm
P5Y10M24D
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2985747
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
358801671
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
230653
CY2021Q1 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
3250
CY2021Q1 us-gaap Assets
Assets
361790668
CY2020Q4 us-gaap Assets
Assets
380653
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
50628
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34395
CY2020Q4 gigu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
125000
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
20475
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
362745
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
230333
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1468
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
435316
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
389749
CY2021Q1 gigu Warrant Liability Non Current
WarrantLiabilityNonCurrent
210025
CY2021Q1 gigu Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
12558000
CY2021Q1 us-gaap Liabilities
Liabilities
13203341
CY2020Q4 us-gaap Liabilities
Liabilities
389749
CY2021Q1 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares
34358732
CY2021Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q1 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
343587320
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11590868
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11590868
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8952000
CY2020Q4 us-gaap Cash
Cash
150000
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
812795
CY2021Q1 us-gaap Cash
Cash
2172952
CY2020Q4 us-gaap Assets Current
AssetsCurrent
150000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34096
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-9096
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
380653
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
361790668
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8952000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1159
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
361901101
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
895
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5646714
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2022952
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2172952
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-22117
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24105
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-647866
CY2021Q1 us-gaap Interest Income Other
InterestIncomeOther
4921
CY2021Q1 gigu Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
70000
CY2021Q1 gigu Fair Value Of Warrant Liability
FairValueOfWarrantLiability
187908
CY2020Q4 gigu Shares Forfeited Subsequent To Expiration Of Underwriters Over Allotment Option
SharesForfeitedSubsequentToExpirationOfUnderwritersOverAllotmentOption
1170000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
595106
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-595106
CY2021Q1 gigu Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
12558000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1468
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-612302
CY2021Q1 gigu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
5185219
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-613770
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-358800000
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
351624000
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
125000
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
593899
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10375485
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-9096
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
187908
CY2021Q1 gigu Temporary Equity Shares Subject To Redemption Value
TemporaryEquitySharesSubjectToRedemptionValue
343587320
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-613770
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000007
CY2021Q1 gigu Stock Split Ratio On Common Stock
StockSplitRatioOnCommonStock
1.2:1
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-613770
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
22117
CY2021Q1 gigu Interest Earned On Cash And Marketable Securities Held In Trust Account
InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount
4921
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
812795
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
26553
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
20454
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
282745
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1468
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1078149
CY2021Q1 us-gaap Payments To Acquire Trust Preferred Investments
PaymentsToAcquireTrustPreferredInvestments
358800000
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-12-04
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
351624000
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
20397899
CY2021Q1 gigu Deferred Underwriting Fees
DeferredUnderwritingFees
12558000
CY2021Q1 gigu Original Offering Cost
OriginalOfferingCost
663899
CY2021Q1 us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes, none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of 100% of the shares of common stock included in the units sold in the Offering (the “public shares”) if the Company is unable to complete a Business Combination within 24 months from the closing of the Offering on February 11, 2021; or (iii) the redemption of the public shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if it does not complete its initial Business Combination within 24 months from the closing of the Offering on February 11, 2021.
CY2021Q1 gigu Common Stock Redemption Percentage
CommonStockRedemptionPercentage
1
CY2021Q1 gigu Public Shares Redemption Percentage
PublicSharesRedemptionPercentage
1
CY2021Q1 gigu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
CY2021Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
358801671
CY2021Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
358800000
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
35880000
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1671
CY2021Q1 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
3250
CY2021Q1 gigu Net Income Loss Attributable To Common Stock Subject To Redemption
NetIncomeLossAttributableToCommonStockSubjectToRedemption
-2582
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-616352
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-613770
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
18000
CY2021Q1 gigu Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
12558000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10375485
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
20397899
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35880000
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 gigu Number Of Shares Of Common Stock Per Unit
NumberOfSharesOfCommonStockPerUnit
1
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q1 gigu Number Of Public Warrants To Be Exercised In Order To Obtain Whole Shares Of Common Stock
NumberOfPublicWarrantsToBeExercisedInOrderToObtainWholeSharesOfCommonStock
3
CY2021Q1 gigu Underwriting Discount Per Unit Paid In Cash
UnderwritingDiscountPerUnitPaidInCash
0.20
CY2021Q1 gigu Deferred Underwriting Commissions Per Unit
DeferredUnderwritingCommissionsPerUnit
0.35
CY2021Q1 us-gaap Share Price
SharePrice
9.83
CY2021Q1 us-gaap Share Price
SharePrice
9.81
CY2021Q1 gigu Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
0.1000
CY2021Q1 gigu Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
0.1000
CY2021Q1 gigu Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
0.0062
CY2021Q1 gigu Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
0.0106
CY2021Q1 gigu Fair Value Assumption Exercise Price
FairValueAssumptionExercisePrice
11.50
CY2021Q1 gigu Fair Value Assumption Exercise Price
FairValueAssumptionExercisePrice
11.50
CY2021Q1 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
3250

Files In Submission

Name View Source Status
0001564590-21-028389-index-headers.html Edgar Link pending
0001564590-21-028389-index.html Edgar Link pending
0001564590-21-028389.txt Edgar Link pending
0001564590-21-028389-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gigu-10q_20210331.htm Edgar Link pending
gigu-10q_20210331_htm.xml Edgar Link completed
gigu-20210331.xsd Edgar Link pending
gigu-20210331_cal.xml Edgar Link unprocessable
gigu-20210331_def.xml Edgar Link unprocessable
gigu-20210331_lab.xml Edgar Link unprocessable
gigu-20210331_pre.xml Edgar Link unprocessable
gigu-ex311_47.htm Edgar Link pending
gigu-ex312_46.htm Edgar Link pending
gigu-ex321_45.htm Edgar Link pending
gigu-ex322_44.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending